As the tenth most common cancer in the world, scientists are working hard to deliver treatments to alleviate the impact of bladder cancer on patients
The current standard of treatment for these patients includes a high-burden version of chemotherapy, followed by radical cystectomy. On top of that, the bladder permeability barrier often makes it difficult for medications to make their way to the tumor. This podcast — provided by Janssen — explains how innovative technologies within the field are changing that.
Check out the podcast episodes below.⬆
- Ep. 5 Changing the Treatment Paradigm for Patients
- Ep. 4 The Importance and Challenges of Early Diagnosis
- Ep. 3 The Transformation of Bladder Cancer Treatments and Role of Genetic Alterations
- Ep. 2 A Clinician's Journey Pt. II
- Ep. 1 A Clinician's Journey Pt. I
Changing the Treatment Paradigm for Patients
In the final episode of Breaking Down Barriers, we highlight the second part of our conversation with Dr. Sam Spigelman. In the last episode, he spoke about the critical importance of early diagnosis when effectively treating bladder cancer and provided some education that can help clinicians and patients navigate diagnosis and treatment. Hear him touch on potentially transformative advances in bladder cancer diagnosis and treatment, discuss why innovation in bladder cancer treatments has been limited and how that is changing now, and talk about genetic alterations, systemic toxicities and why avoiding bladder surgery and removal is so important.